NovoCure Limited

Healthcare · Medical Devices · Switzerland

Last price 13.11 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.53B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Lim...